Androgen receptor splice variant 7 in castration-resistant prostate cancer: Clinical considerations
Author:
Affiliation:
1. Division of Hematology and Medical Oncology; Mayo Clinic; Scottsdale Arizona USA
2. Departments of Oncology and Urology; Johns Hopkins Sidney Kimmel Comprehensive Cancer Center; Baltimore Maryland USA
Funder
Prostate Cancer Foundation
Patrick C. Walsh Fund
National Institutes of Health
Publisher
Wiley
Subject
Urology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/iju.13134/fullpdf
Reference44 articles.
1. Interrogating androgen receptor function in recurrent prostate cancer;Zhang;Cancer Res.,2003
2. Starving the addiction: new opportunities for durable suppression of AR signaling in prostate cancer;Knudsen;Clin. Cancer Res.,2009
3. Molecular determinants of resistance to antiandrogen therapy;Chen;Nat. Med.,2004
4. Intratumoral de novo steroid synthesis activates androgen receptor in castration-resistant prostate cancer and is upregulated by treatment with CYP17A1 inhibitors;Cai;Cancer Res.,2011
5. Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer;Watson;Nat. Rev. Cancer,2015
Cited by 24 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Co-expression of Twist and Snai1: predictor of poor prognosis and biomarker of treatment resistance in untreated prostate cancer;Molecular Biology Reports;2024-01-28
2. Beyond Prostate Cancer: An Androgen Receptor Splice Variant Expression in Multiple Malignancies, Non-Cancer Pathologies, and Development;Biomedicines;2023-08-07
3. The prognostic value of androgen to PSA ratio in predictive modeling of prostate cancer;Medical Hypotheses;2023-07
4. Intracellular interaction of FNDC1/FN1/AR/cMYC in prostate cancer cells;2023-02-23
5. A novel biguanide derivative, IM176, induces prostate cancer cell death by modulating the AMPK-mTOR and androgen receptor signaling pathways;Prostate International;2022-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3